Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Taiwan Advance Bio-Pharmaceutical, Inc. (4186) Financial Statements

1 Followers

Taiwan Advance Bio-Pharmaceutical, Inc. Financial Overview

Taiwan Advance Bio-Pharmaceutical, Inc.'s market cap is currently NT$625.50M. The company's EPS TTM is NT$0.17; its P/E ratio is 40.88; Taiwan Advance Bio-Pharmaceutical, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 364.79MNT$ 354.17MNT$ 315.98MNT$ 318.24MNT$ 243.36M
Gross ProfitNT$ 227.30MNT$ 243.97MNT$ 198.46MNT$ 192.58MNT$ 124.79M
Operating IncomeNT$ 29.00MNT$ 44.84MNT$ 4.27MNT$ 7.61MNT$ -102.82M
EBITDANT$ 48.67MNT$ 50.65MNT$ 21.81MNT$ 38.00MNT$ -76.69M
Net IncomeNT$ 28.05MNT$ 22.88MNT$ -10.68MNT$ 3.17MNT$ -118.53M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 140.74MNT$ 106.32MNT$ 182.14MNT$ 158.56MNT$ 159.69M
Total AssetsNT$ 746.74MNT$ 676.42MNT$ 748.57MNT$ 706.77MNT$ 713.74M
Total DebtNT$ 272.69MNT$ 235.62MNT$ 320.13MNT$ 290.79MNT$ 256.26M
Net DebtNT$ 131.96MNT$ 129.30MNT$ 138.00MNT$ 132.24MNT$ 96.56M
Total LiabilitiesNT$ 461.64MNT$ 419.98MNT$ 514.65MNT$ 462.13MNT$ 472.29M
Stockholders' EquityNT$ 285.10MNT$ 256.44MNT$ 233.92MNT$ 244.64MNT$ 241.45M
Cash Flow
Free Cash FlowNT$ 17.18MNT$ 4.37MNT$ 667.00KNT$ -27.87MNT$ -62.29M
Operating Cash FlowNT$ 50.54MNT$ 8.33MNT$ 12.61MNT$ -20.59MNT$ -48.08M
Investing Cash FlowNT$ -48.25MNT$ -2.22MNT$ -13.70MNT$ -8.83MNT$ -15.20M
Financing Cash FlowNT$ 32.12MNT$ -81.92MNT$ 24.67MNT$ 28.28MNT$ -13.92M

Currency in TWD

Taiwan Advance Bio-Pharmaceutical, Inc. Earnings and Revenue History

-250M0250M500M-100 %-50 %0 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Taiwan Advance Bio-Pharmaceutical, Inc. Liabilities to Assets

0300M600M900M0 %30 %60 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Taiwan Advance Bio-Pharmaceutical, Inc. Cash Flow

-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Taiwan Advance Bio-Pharmaceutical, Inc. Forecast EPS vs Actual EPS

Earnings >